Aviva’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-24,583
Closed -$1.29M 1014
2023
Q2
$1.29M Buy
24,583
+619
+3% +$37.7K 0.01% 792
2023
Q1
$1.53M Buy
23,964
+6,249
+35% +$408K 0.01% 715
2022
Q4
$860K Sell
17,715
-448
-2% -$28.1K ﹤0.01% 926
2022
Q3
$1.28M Buy
+18,163
New +$1.55M 0.01% 885
2022
Q2
Sell
-10,117
Closed -$808K 1107
2022
Q1
$808K Buy
10,117
+2,757
+37% +$205K ﹤0.01% 986
2021
Q4
$672K Sell
7,360
-3,053
-29% -$328K ﹤0.01% 971
2021
Q3
$1.34M Buy
+10,413
New +$1.46M 0.01% 914
2021
Q2
Sell
-12,545
Closed -$1.32M 969
2021
Q1
$1.32M Sell
12,545
-10,210
-45% -$1.02M 0.01% 747
2020
Q4
$1.8M Sell
22,755
-18,448
-45% -$1.35M 0.01% 700
2020
Q3
$2.33M Buy
41,203
+3,994
+11% +$215K 0.01% 666
2020
Q2
$2.29M Sell
37,209
-80,624
-68% -$3.29M 0.01% 706
2020
Q1
$3.8M Buy
+117,833
New +$3.97M 0.03% 492

Other funds holding STAA

Aviva's STAA Position: Q3 2023 in Review

Aviva sold out of STAAR Surgical (STAA) in Q3 2023, closing a stake of 24,583 shares — an estimated $1.29M sold.

Aviva first reported a position in STAA in Q1 2020 and held it in 12 quarters. The position peaked at $3.8M in Q1 2020. 217 funds tracked by Wall St. Rank hold STAA as of Q3 2023.

  • Aviva reported no remaining STAAR Surgical position as of Q3 2023 after selling out during the quarter.
  • Aviva sold 24,583 STAAR Surgical shares in Q3 2023, an estimated $1.29M.
  • Aviva first reported a position in STAAR Surgical in Q1 2020 and held it in 12 quarters.
  • Aviva's STAAR Surgical position peaked at $3.8M in Q1 2020.
  • 217 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2023.

Based on Aviva's 13F filing for Q3 2023, filed 13 Nov 2023.